Viatris brand of azelastine hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 14 USDMF, 7 CEP/COS, 2 JDMF, 4 EU WC, 12 KDMF, 14 NDC API, 13 Listed Suppliers

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 40 FDA Orange Book, 154 Europe, 3 Canada, 3 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 3 SPI Pharma, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 5 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 11 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 1 Gloria Interchem, 4 Ideal Cures, 10 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 12 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Silverline Chemicals, 3 The Dow Chemical Company, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 23 Fillers, Diluents & Binders, 21 Parenteral, 19 Thickeners and Stabilizers, 17 Film Formers & Plasticizers, 16 Controlled & Modified Release, 16 Solubilizers, 11 Taste Masking, 11 Direct Compression, 9 Co-Processed Excipients, 9 API Stability Enhancers, 7 Granulation, 6 Chewable & Orodispersible Aids, 6 Disintegrants & Superdisintegrants, 6 Topical, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Lubricants & Glidants, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 36 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 14 Annual Reports

MARKET PLACE

16 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 16 Others

Xls

Filters

Viatris Brand Of Azelastine Hydrochloride

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

PEGS Boston Summit

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

PEGS Boston Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Viatris brand of azelastine hydrochloride? Find Coloring Agents used in Viatris brand of azelastine hydrochloride to address drug delivery challenges on PharmaCompass.

Viatris brand of azelastine hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers

14 USDMF

7 CEP/COS

2 JDMF

4 EU WC

12 KDMF

14 NDC API

13 Listed Suppliers

DEVELOPMENTS

20 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers

40 FDA Orange Book

154 Europe

3 Canada

3 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

3 SPI Pharma

1 Pharm-RX Chemical

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

6 Kirsch Pharma

5 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

11 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

1 Bioplus Life Sciences

1 CD Formulation

10 Corel Pharma Chem

2 DFE Pharma

1 Finar

8 Gangwal Chemicals

1 Gloria Interchem

4 Ideal Cures

10 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

6 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

1 Prachin Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

12 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

1 Silverline Chemicals

3 The Dow Chemical Company

1 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives

23 Fillers, Diluents & Binders

21 Parenteral

19 Thickeners and Stabilizers

17 Film Formers & Plasticizers

SPRAY, METERED;NASAL - 0.137MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION/DROPS;OPHTHALMIC - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.137MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons